Pharmaceutical Company
Patent Quality Improvement Act of 2013 (S. 866, H.R. 2766), Patent Abuse Reduction Act of 2013 (S. 1013, H.R. 2639); The Innovation Act (HR 3309); Patent Transparency and Improvements Act of 2013 (S. 1720); General issues related to intellectual property and potential changes to the patent system Orphan Drug Tax Credit; Research and Development Tax Credit FDA - rare and orphan disease issues
CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
ANDREA LARUE LISA GERMAN FOSTER LISA GERMAN FOSTER